CDC panel recommends smokers get pneumococcal vaccine
This article was originally published in Scrip
Executive Summary
The US Centers for Disease Control and Prevention's advisory committee on immunisation practices (ACIP) has made a recommendation that all adult smokers receive the approved pneumococcal vaccine, just like people aged over age 65. Merck & Cois the sole supplier of the 23-valent pneumococcal polysaccharide vaccine, known as Pneumovax 23, in the US.